| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $468.0M | +26.7% |
| Cost of Revenue | $133.3M | +28.1% |
| Gross Profit | $334.7M | +26.2% |
| R&D Expense | $139.2M | +42.8% |
| SG&A Expense | $120.1M | +43.5% |
| Operating Income | -$145.0M | -72.8% |
| Pre-tax Income | -$150.2M | -71.0% |
| Income Tax | $692K | -11.1% |
| Net Income | -$150.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $148.1M | +47.0% |
| Short-term Investments | $47.9M | -13.3% |
| Accounts Receivable | $166.0M | +27.6% |
| Current Assets | $422.5M | +24.9% |
| Total Assets | $594.2M | +17.8% |
| Current Liabilities | $270.3M | +25.3% |
| Long-term Debt | $118.1M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$106.6M | -97.6% |
| Capital Expenditures | $9.1M | +50.1% |
| Investing Cash Flow | $10.3M | -75.5% |
| Financing Cash Flow | $142.9M | +5028.0% |
| Free Cash Flow | -$115.6M | -92.8% |
| -70.3% |
| EPS (Basic) | -$2.08 | -66.4% |
| EPS (Diluted) | -$2.08 | -66.4% |
| Total Liabilities |
| $448.5M |
| +65.7% |
| Stockholders' Equity | $145.7M | -37.7% |